From Medscape Diabetes & Endocrinology

Coverage from the

European Association for the Study of Diabetes (EASD) 2023 Annual Meeting

October 02 - 06, 2023; Hamburg, Germany

October 02 - 06, 2023 Hamburg, Germany

Conference News

EASD 2023 Common Meds Link to Sudden Cardiac Arrest in Type 2 Diabetes
Medscape Medical News, October 23, 2023
EASD 2023 Testosterone Replacement Benefits Men With Type 2 Diabetes
Medscape Medical News, October 17, 2023
EASD 2023 New 'Twincretin' Pemvidutide: Another Option for Obesity
Medscape Medical News, October 16, 2023
EASD 2023 New Hyperglycemia Emergency Guidance Updates DKA Definition
Medscape Medical News, October 9, 2023
EASD 2023 Tirzepatide Weight Loss Continues On and Off Drug at 1 Year
Medscape Medical News, October 6, 2023
EASD 2023 Respiratory Infections, Asthma Rise Before Type 2 Diabetes
Medscape Medical News, October 5, 2023
EASD 2023 Precision Medicine Takes Individual Approach to Diabetes
Medscape Medical News, October 5, 2023
EASD 2023 Antivirals Slow Insulin Loss in New-Onset Type 1 Diabetes
Medscape Medical News, October 4, 2023
EASD 2023 'Untapped Opportunity': Diabetes Screening in the ER
Medscape Medical News, October 4, 2023

EASD 2023 Weight Loss With Semaglutide Maintained for up to 3 Years
Medscape Medical News, October 3, 2023
EASD 2023 Tirzepatide With Insulin Glargine Improves Type 2 Diabetes
Medscape Medical News, October 3, 2023
EASD 2023 Metformin Treatment Shows Benefit in Gestational Diabetes
Medscape Medical News, October 3, 2023
EASD 2023 Menstruation Linked to Underdiagnosis of Type 2 Diabetes?
Medscape Medical News, October 2, 2023
EASD 2023 EASD 2023: A Deeper Dive Into Type 1 and Type 2 Diabetes
Medscape Medical News, September 26, 2023
EASD 2023 Tirzepatide Tops Semaglutide for A1c Control, Weight Loss
Medscape Medical News, September 22, 2023
EASD 2023 Heart Attack Deaths Static in Those With Type 1 Diabetes
Medscape Medical News, September 13, 2023
EASD 2023 Low-Dose Aspirin Cuts Type 2 Diabetes Risk in Over-65s
Medscape Medical News, September 1, 2023

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Obesity in Diabetes: Highlights From EASD 2023
Carol H. Wysham, MD
Glycemic Control in T2D: Highlights From EASD 2023
Anne L. Peters, MD
Comorbidities in Diabetes: Key Updates From EASD 2023
Carol H. Wysham, MD
Advances in Insulin Therapy for Type 2 Diabetes From EASD 2023
Anne L. Peters, MD
Hope for Patients With T1D and Chronic Kidney Disease
Kevin Fernando, MBChB, MSc
Maintenance of Weight Loss Is Not an Insurmountable Task
Kevin Fernando, MBChB, MSc
Is Lasting Remission of T2D Feasible in the Real World?
Kevin Fernando, MBChB, MSc
From NAFLD to MASLD: What's in a Name?
Kevin Fernando, MBChB, MSc

Popular News From EASD 2022

Eat More Dairy, Less Red Meat to Prevent Type 2 Diabetes Not all animal foods are alike when it comes to their association with type 2 diabetes risk, shows a large new review. The devil is in the details.
Medscape Medical News, Sep 20, 2022
Waist-Hip Ratio Beats BMI for Predicting Mortality Risk Data from more than 380,000 people in the UK Biobank show waist-to-hip ratio predicted mortality risk from obesity better than BMI or fat mass index.
Medscape Medical News, Sep 20, 2022
'Game Changer' Semaglutide Halves Diabetes Risk From Obesity Post-hoc analysis of two semaglutide trials in people with obesity showed treatment cut their projected 10-year risk for incident type 2 diabetes.
Medscape Medical News, Sep 19, 2022

Previous Coverage